galacto-Dapagliflozin

• CAT Number: I011794
• CAS Number: 1408245-02-2
• Molecular Formula: C21H25ClO6
• Molecular Weight: 408.9
• Purity: ≥95%
• Synonyms: (1S)-1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-galactitol
• Target: SGLT
• Solubility: Soluble in DMSO
• Storage: Store at -20°C
• InChIKey: JVHXJTBJCFBINQ-IFLJBQAJSA-N

Galacto-Dapagliflozin(CAT: I011794) is a synthetic derivative of dapagliflozin, which is a sodium-glucose co-transporter 2 (SGLT2) inhibitor used in the treatment of type 2 diabetes. Galacto-Dapagliflozin has an additional galactose moiety attached to the dapagliflozin molecule, which can enhance its pharmacokinetic properties and reduce the risk of adverse effects. Like dapagliflozin, Galacto-Dapagliflozin works by inhibiting SGLT2, a transporter protein responsible for glucose reabsorption in the kidneys, resulting in increased urinary glucose excretion and improved glycemic control. Galacto-Dapagliflozin is still undergoing clinical trials for its potential use in treating type 2 diabetes.